activins has been researched along with Chronic Kidney Diseases in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (60.00) | 24.3611 |
| 2020's | 8 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoffman, HM; Mak, RH; Perens, EA | 1 |
| Ikizler, TA; Terker, AS | 1 |
| Aniort, J; Bartoli, M; Bataille, S; Burtey, S; Chermiti, R; Da Silva, N; Dou, L; Ferkak, B; McKay, N; Poitevin, S; Sallée, M | 1 |
| Gao, B; Kakoki, M; Khajehei, M; Krepinsky, JC; Li, R; MacDonald, M; O'Neil, K; Soomro, A; Zhang, D | 1 |
| Chou, RH; Huang, PH; Lin, SJ; Liu, CT; Lu, YW; Tsai, YL | 1 |
| Capelli, I; Cianciolo, G; Ciceri, P; Cozzolino, M; Galassi, A; Gasperoni, L; La Manna, G | 1 |
| Boor, P; Cohen, CD; Eichinger, F; Hoxha, E; Huber, TB; Kilic, T; Klinkhammer, BM; Kretz, O; Kretzler, M; Kylies, D; Lindenmeyer, MT; Liu, S; Lu, S; Martin, IV; Matsakas, A; Menon, R; Meyer, C; Mitchell, R; Nair, V; Omairi, S; Ostendorf, T; Paolini, A; Pasternack, A; Patel, K; Puelles, VG; Ritvos, O; Sandri, M; Solagna, F; Tezze, C; Tharaux, PL; Turner, JE; Wanner, N; Wiesch, JSZ; Wu, G; Zhao, Y | 1 |
| Cipriani, L; Esposito, P; Garibotto, G; Picciotto, D; Verzola, D; Viazzi, F | 1 |
| Borawski, J; Gozdzikiewicz-Lapinska, J; Koc-Zorawska, E; Mysliwiec, M; Naumnik, B; Rydzewska-Rosolowska, A | 1 |
| Del Vecchio, L; Locatelli, F; Luise, MC | 1 |
| Jelkmann, W | 1 |
| Barisione, C; Garibotto, G; Koppe, L; Picciotto, D; Verzola, D | 1 |
| Davenport, DL; El-Husseini, AA; Lima, F; Malluche, HH; Mawad, H | 1 |
| Ott, SM | 1 |
| Gao, B; Gava, AL; Krepinsky, JC; Mehta, N; Zhang, D | 1 |
| Egstrand, S; Gravesen, E; Lewin, E; Mace, ML; Morevati, M; Nordholm, A; Olgaard, K | 1 |
| Bonomini, M; Del Vecchio, L; Locatelli, F; Sirolli, V | 1 |
| Drueke, TB; Massy, ZA | 1 |
| Agapova, OA; Berman, AG; Fang, Y; Faugere, MC; Hruska, KA; Malluche, HH; Smith, W; Sugatani, T; Sung, V; Wallace, JM | 1 |
| D'Haese, PC; Evenepoel, P; Verhulst, A | 1 |
7 review(s) available for activins and Chronic Kidney Diseases
| Article | Year |
|---|---|
The role of activin: the other side of chronic kidney disease-mineral bone disorder?
Topics: Activins; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Minerals; Renal Insufficiency, Chronic | 2021 |
Myostatin/Activin-A Signaling in the Vessel Wall and Vascular Calcification.
Topics: Activins; Animals; Atherosclerosis; Blood Vessels; Humans; Myostatin; Renal Insufficiency, Chronic; Signal Transduction; Vascular Calcification; Vascular Remodeling | 2021 |
Current and future chemical therapies for treating anaemia in chronic kidney disease.
Topics: Activin Receptors, Type II; Activins; Anemia; Erythropoiesis; Hematinics; Humans; Hypoxia-Inducible Factor 1; Immunoglobulin Fc Fragments; Iron; Recombinant Fusion Proteins; Renal Insufficiency, Chronic; Treatment Outcome | 2017 |
Activin receptor ligand traps in chronic kidney disease.
Topics: Activin Receptors; Activin Receptors, Type II; Activins; Anemia; Animals; Erythropoiesis; Hematinics; Humans; Immunoglobulin Fc Fragments; Ligands; Recombinant Fusion Proteins; Renal Insufficiency, Chronic; Transforming Growth Factor beta | 2018 |
Emerging role of myostatin and its inhibition in the setting of chronic kidney disease.
Topics: Activin Receptors, Type II; Activins; Anabolic Agents; Animals; Clinical Trials as Topic; Disease Models, Animal; Exercise Therapy; Feeding Behavior; Humans; Muscle, Skeletal; Myostatin; Proteolysis; Renal Insufficiency, Chronic; Sarcopenia; Signal Transduction; Treatment Outcome | 2019 |
Renal insufficiency and bone loss.
Topics: Activins; Bone and Bones; Chronic Kidney Disease-Mineral and Bone Disorder; Disease Progression; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Renal Insufficiency, Chronic; Wnt Proteins | 2019 |
New Treatment Approaches for the Anemia of CKD.
Topics: Activins; Anemia; Hematinics; Humans; Receptors, Erythropoietin; Renal Insufficiency, Chronic | 2016 |
13 other study(ies) available for activins and Chronic Kidney Diseases
| Article | Year |
|---|---|
Activin A Signaling Provides an Interorgan Link Between Kidney and Muscle in CKD-Associated Muscle Wasting.
Topics: Activins; Humans; Kidney; Muscles; Renal Insufficiency, Chronic | 2022 |
Untangling the fibers of sarcopenia: activin A in chronic kidney disease-associated muscle wasting.
Topics: Activins; Humans; Muscles; Muscular Atrophy; Renal Insufficiency, Chronic; Sarcopenia | 2022 |
Mechanisms of myostatin and activin A accumulation in chronic kidney disease.
Topics: Activins; Animals; Humans; Indican; Mammals; Mice; Muscle, Skeletal; Myostatin; Renal Insufficiency, Chronic | 2022 |
A therapeutic target for CKD: activin A facilitates TGFβ1 profibrotic signaling.
Topics: Activins; Animals; Fibrosis; Mice; Renal Insufficiency, Chronic; Transforming Growth Factor beta | 2023 |
Serum Activin A Levels and Renal Outcomes After Coronary Angiography.
Topics: Activins; Aged; Contrast Media; Coronary Angiography; Creatinine; Female; Heart Failure; Humans; Kidney; Male; Middle Aged; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors | 2020 |
Pro-cachectic factors link experimental and human chronic kidney disease to skeletal muscle wasting programs.
Topics: Activin Receptors, Type II; Activins; Animals; Cachexia; Disease Models, Animal; HEK293 Cells; Humans; Mice; Mice, Knockout; Muscle, Skeletal; Muscular Atrophy; Renal Insufficiency, Chronic; Wasting Syndrome | 2021 |
Unexpected and striking effect of heparin-free dialysis on cytokine release.
Topics: Activins; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Chemokine CCL2; Endostatins; Enoxaparin; Female; Heparin; Humans; Male; Membranes, Artificial; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic; Young Adult | 2017 |
Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers
.
Topics: Activins; Adaptor Proteins, Signal Transducing; Adult; Aged; Aged, 80 and over; Biomarkers; Bone Morphogenetic Proteins; Bone Remodeling; Case-Control Studies; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Genetic Markers; Glomerular Filtration Rate; Glucuronidase; Humans; Inhibin-beta Subunits; Intercellular Signaling Peptides and Proteins; Kidney Failure, Chronic; Klotho Proteins; Male; Middle Aged; Parathyroid Hormone; PAX5 Transcription Factor; Renal Insufficiency, Chronic; Severity of Illness Index; Tartrate-Resistant Acid Phosphatase; Vitamin D | 2019 |
Follistatin Protects Against Glomerular Mesangial Cell Apoptosis and Oxidative Stress to Ameliorate Chronic Kidney Disease.
Topics: Activins; Animals; Antioxidants; Apoptosis; Calcium; Endoplasmic Reticulum Stress; Fibrosis; Follistatin; Gene Expression; Gene Expression Regulation; Kidney Function Tests; Lactones; Mesangial Cells; Mice; NADPH Oxidase 4; Oxidative Stress; Reactive Oxygen Species; Renal Insufficiency, Chronic; RNA Interference; RNA Processing, Post-Transcriptional; RNA, Small Interfering; Sesquiterpenes | 2019 |
Circadian rhythm of activin A and related parameters of mineral metabolism in normal and uremic rats.
Topics: Activins; Animals; Bone Diseases, Metabolic; Circadian Rhythm; Fibroblast Growth Factors; Glucuronidase; Klotho Proteins; Male; Parathyroid Hormone; Phosphates; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Uremia | 2019 |
Activin receptor IIA ligand trap in chronic kidney disease: 1 drug to prevent 2 complications-or even more?
Topics: Activin Receptors; Activins; Humans; Ligands; Renal Insufficiency, Chronic; Signal Transduction | 2016 |
Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease.
Topics: Activins; Animals; Bone Remodeling; Cells, Cultured; Chronic Kidney Disease-Mineral and Bone Disorder; Diabetes Mellitus, Experimental; Disease Models, Animal; Glomerular Filtration Rate; Hyperphosphatemia; Male; Mice; Mice, Knockout; Osteoblasts; Osteoclasts; Receptors, LDL; Recombinant Fusion Proteins; Renal Insufficiency, Chronic; Vascular Calcification; X-Ray Microtomography | 2017 |
Ligand trap for the activin type IIA receptor. The long-sought drug to overcome the calcification paradox in CKD?
Topics: Activin Receptors; Activins; beta Catenin; Calcification, Physiologic; Renal Insufficiency, Chronic; Vascular Calcification | 2017 |